Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Apremilast> ?p ?o. }
Showing items 1 to 52 of
52
with 100 items per page.
- Apremilast abstract "Apremilast (proprietary commercial name Otezla) is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It has anti-inflammatory activity.".
- Apremilast atcPrefix "L04".
- Apremilast atcSuffix "AA32".
- Apremilast bioavailability "73.0".
- Apremilast iupacName "N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide".
- Apremilast pubchem "11561674".
- Apremilast thumbnail Apremilast.svg?width=300.
- Apremilast wikiPageID "36936791".
- Apremilast wikiPageRevisionID "601598674".
- Apremilast atcPrefix "L04".
- Apremilast atcSuffix "AA32".
- Apremilast bioavailability "73.0".
- Apremilast c "22".
- Apremilast chemspiderid "9736448".
- Apremilast drugName "Apremilast".
- Apremilast eliminationHalfLife "-32400.0".
- Apremilast excretion "Urine , faeces".
- Apremilast h "24".
- Apremilast hasPhotoCollection Apremilast.
- Apremilast inchi "1".
- Apremilast inchikey "IMOZEMNVLZVGJZ-QGZVFWFLBB".
- Apremilast iupacName "N-{2-[-1--2-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide".
- Apremilast legalUs "Rx-only".
- Apremilast metabolism "Hepatic".
- Apremilast molecularWeight "460.5".
- Apremilast n "2".
- Apremilast o "7".
- Apremilast pregnancyUs "C".
- Apremilast proteinBound "68.0".
- Apremilast pubchem "11561674".
- Apremilast s "1".
- Apremilast smiles "O=SC[C@H]N3Cc2ccccNCC".
- Apremilast stdinchi "1".
- Apremilast stdinchikey "IMOZEMNVLZVGJZ-QGZVFWFLSA-N".
- Apremilast tradename "Otezla".
- Apremilast subject Category:Acetamides.
- Apremilast subject Category:PDE4_inhibitors.
- Apremilast subject Category:Phenol_ethers.
- Apremilast subject Category:Phthalimides.
- Apremilast type Drug.
- Apremilast type FunctionalSubstance.
- Apremilast comment "Apremilast (proprietary commercial name Otezla) is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It has anti-inflammatory activity.".
- Apremilast label "Apremilast".
- Apremilast label "Apremilast".
- Apremilast sameAs Apremilast.
- Apremilast sameAs m.052vhw8.
- Apremilast sameAs Q2858961.
- Apremilast sameAs Q2858961.
- Apremilast wasDerivedFrom Apremilast?oldid=601598674.
- Apremilast depiction Apremilast.svg.
- Apremilast isPrimaryTopicOf Apremilast.
- Apremilast name "Apremilast".